02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.95
−2.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 16.99x
- P/S forward
- 24.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.88x
- Price / sales
- 39.30x
- Price / cash flow
- -30.75x
Enterprise value
- Enterprise value
- HKD 4.8B
- EV / sales
- 29.53x
- EV / EBITDA
- -21.07x
- EV / EBIT
- -40.81x
- Market cap
- HKD 6.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026